News Novartis invests $100m in new malaria drugs Concerns are mounting over resistance to artemisinin
News Sanofi in talks with Evotec to out-licence antibiotic resear... Evotec to collaborate with academia, pharma and biotech on new antimicrobials
News ViiV's HIV drug could be used for TB co-infection patients Interim results suggest new treatment option for patients with TB and HIV
News Gilead takes 'HIV eradication' combo into clinic New approach tackles reserve of HIV within the body
News Call for new restrictions on UK vaccine prices Proposals also include fresh attack on drug prices
News Court sides with EU on decision to revoke Ocaliva's license Advanz Pharma's bid to keep its Ocaliva treatment for rare liver disease primary biliary cholangitis (PBC) on the EU market has ended in failure
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
